Skin Lymphomas

A man in his 50s with a history of itchy eruptions presented with extensive dry, scaly patches and nodules on his trunk and extremities. What is your diagnosis?

This case series report of mogamulizumab-associated cutaneous granulomatous drug eruption (CGDE) describes 12 patients with mycosis fungoides (MF) whose CGDE mimicked the MF but was followed by durable clinical MF response.

A man in his 40s with a history of pruritic patches and plaques presented with expanding lesions on the flanks. What is your diagnosis?

This matched-cohort study of patients with acute myeloid leukemia with and without leukemia cutis assesses the association of leukemia cutis with survival.

This randomized clinical trial examines whether the use of psoralen–UV-A with maintenance therapy can prolong clinical response and disease remission in patients with early-stage mycosis fungoides.

A man in his 50s presented with an abdominal skin eruption of 2 days’ duration; his medical history included hepatitis C, cirrhosis, and an orthotopic liver transplant 3 years prior. What is your diagnosis?

A man in his 60s presented with lip enlargement with erythematous and flesh-colored papules and nodules symmetrically affecting the upper and lower lips. What is your diagnosis?

This systematic review and meta-analysis compares response and adverse effects of psoralen–UV-A with narrowband UV-B phototherapy in patients with early-stage mycosis fungoides.

This case series study examines the association between APOA5 and APOC3 polymorphisms and triglyceride levels in patients with cutaneous T-cell lymphoma before, during, and after treatment with bexarotene.

This randomized clinical trial assesses whether treatment with the neurokinin 1 receptor antagonist aprepitant decreases pruritus vs placebo in patients with Sézary syndrome.

This preclinical in vitro study identifies novel small molecules that induce extrinsic apoptosis and serve as an alternative treatment for cutaneous T-cell lymphoma.

This virological study examines the association of cutavirus DNA with different types of cutaneous B-cell lymphoma and cutaneous T-cell lymphoma in lesional skin samples.

This case series examines the characteristics of cutaneous T-cell lymphoma associated with hemophagocytic lymphohistiocytosis and analyzes the presenting signs and symptoms, therapeutic options, and outcomes.

This case series describes the occurrence of graft-vs-host-disease (GVHD) in patients with cutaneous T-cell lymphomas (CTCLs) treated with the CC chemokine receptor 4 (CCR4) antibody mogalizumab prior to allogeneic hematopoietic stem cell transplantation (HSCT).

This case report describes a patient with cutaneous T-cell lymphoma who developed methotrexate-associated B-cell lymphoproliferative disease.

This case report describes the treatment of CD30-negative refractory mycosis fungoides with brentuximab vedotin.

This phase 2 trial of 12 patients assesses the efficacy and safety of brentuximab vedotin for lymphomatoid papulosis.